Prevalence and factors associated with peripheral neuropathy in a setting of retail pharmacies in Malaysia-A cross-sectional study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2024
2024
Historique:
received:
04
09
2023
accepted:
28
06
2024
medline:
29
10
2024
pubmed:
29
10
2024
entrez:
29
10
2024
Statut:
epublish
Résumé
Peripheral neuropathy is a common cause for neurological consultation, especially among those with diabetes mellitus. However, research on peripheral neuropathy among the general population is lacking in Malaysia. This study aimed to determine the prevalence and factors associated with peripheral neuropathy in a setting of retail pharmacies. This cross-sectional study of 1283 participants was conducted at retail pharmacies in Selangor. Peripheral neuropathy was defined as the final score in the mild to severe category in the severity rating scale using a biothesiometer. SPSS version 26 was used to perform the analysis. Multiple logistic regressions were used to determine the factors associated with peripheral neuropathy. The prevalence of peripheral neuropathy based on the biothesiometer was 26.5%. According to multiple logistic regression, the predictors of peripheral neuropathy were those who have diabetes (AOR = 3.901), aged more than 50 years (AOR = 3.376), have secondary education or below (AOR = 2.330), are male (AOR = 1.816), and have underlying hypertension (AOR = 1.662). Peripheral neuropathy is a reasonably prevalent condition, affecting a quarter of the general population, and often goes undiagnosed. It is crucial for healthcare providers to proactively screen for peripheral neuropathy, particularly in high-risk populations, to prevent potential complications.
Identifiants
pubmed: 39471189
doi: 10.1371/journal.pone.0307093
pii: PONE-D-23-27646
pmc: PMC11521241
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0307093Informations de copyright
Copyright: © 2024 Ching et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
Authors are required to disclose financial or non-financial interests that are directly or indirectly related to the work submitted for publication.
Références
Indian J Med Res. 2011 Jun;133:645-9
pubmed: 21727664
Front Endocrinol (Lausanne). 2020 Jan 17;10:929
pubmed: 32010062
Vasc Health Risk Manag. 2007;3(1):65-76
pubmed: 17583176
Neurology. 1991 Aug;41(8):1315-7
pubmed: 1650932
J Diabetes Investig. 2020 Sep;11(5):1097-1103
pubmed: 32268012
BMJ Open Diabetes Res Care. 2021 May;9(1):
pubmed: 34006607
Diabetes Care. 2005 Apr;28(4):956-62
pubmed: 15793206
Mayo Clin Proc. 2015 Jul;90(7):940-51
pubmed: 26141332
Prim Care Diabetes. 2020 Oct;14(5):435-444
pubmed: 31917119
BMJ. 2002 Feb 23;324(7335):466-9
pubmed: 11859051
Acta Neuropathol. 2012 Oct;124(4):561-73
pubmed: 22791295
Ann Intern Med. 2021 Feb;174(2):167-174
pubmed: 33284680
Med J Malaysia. 2003 Oct;58(4):533-8
pubmed: 15190629
Int Arch Med. 2012 Aug 15;5(1):23
pubmed: 22894705
Cardiovasc Diabetol. 2018 Nov 28;17(1):150
pubmed: 30486889
Ann Indian Acad Neurol. 2008 Apr;11(2):89-97
pubmed: 19893645
Nat Rev Endocrinol. 2021 Jul;17(7):400-420
pubmed: 34050323
Hum Exp Toxicol. 2014 Jan;33(1):92-102
pubmed: 23703814
Diabetes Metab Syndr. 2012 Jul-Sep;6(3):167-72
pubmed: 23158982